ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$36.13
-0.69 (-1.87%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+141.51%
YTD
+64.75%
Open$36.64
Previous Close$36.82
Day High$36.75
Day Low$35.91
52W High$42.50
52W Low$14.50
Volume—
Avg Volume8.99M
Market Cap28.53B
P/E Ratio—
EPS$-0.39
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.00
Above
SMA 200
$16.34
Above
RSI (14)
76.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+122.6% upside
Current
$36.13
$36.13
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.54M | 16.65M | 2.76B |
| Net Income | -309,925,055 | -544,046,322 | -140,854,131 |
| Profit Margin | -3,629.2% | -3,447.7% | -5.1% |
| EBITDA | -517,689,629 | -959,245,460 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -48.7% | -48.7% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.12 | +0.02% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.04 | -0.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $149.69 | -1.11% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $522.38 | +1.17% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $796.02 | -0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $249.59 | +1.25% | 40.0 | 32.33B |